Compare LYRA & BYAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYRA | BYAH |
|---|---|---|
| Founded | 2005 | 2016 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 5.6M |
| IPO Year | 2020 | 2024 |
| Metric | LYRA | BYAH |
|---|---|---|
| Price | $1.97 | $0.16 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | 104.0K | ★ 216.2K |
| Earning Date | 11-12-2025 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $600,000.00 | ★ $2,768,120.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $93.90 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 42.65 |
| 52 Week Low | $1.63 | $0.14 |
| 52 Week High | $37.50 | $41.49 |
| Indicator | LYRA | BYAH |
|---|---|---|
| Relative Strength Index (RSI) | 27.52 | N/A |
| Support Level | $1.63 | N/A |
| Resistance Level | $3.94 | N/A |
| Average True Range (ATR) | 0.25 | 0.00 |
| MACD | -0.14 | 0.00 |
| Stochastic Oscillator | 15.37 | 0.00 |
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.